Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply

被引：0
|
作者：
Faye, Adam S. [1 ,2 ,4 ]
Jess, Tine [2 ,3 ]
机构：
[1] New York Univ, Dept Med & Populat Hlth, Grossman Sch Med, New York, NY USA
[2] Aalborg Univ, Ctr Mol Predict Inflammatory Bowel Dis, Dept Clin Med, Copenhagen, Denmark
[3] Aalborg Univ, Dept Gastroenterol & Hepatol, Aalborg, Denmark
[4] New York Univ, Grossman Sch Med, New York, NY 10016 USA
来源：
GUT | 2023年
关键词：
IBD; ANTIBIOTICS; CROHN'S DISEASE; ULCERATIVE COLITIS;
D O I：
10.1136/gutjnl-2023-329851
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antibiotic use and inflammatory bowel disease: number needed to harm?
    Ludvigsson, Jonas F.
    GUT, 2024, 73 (04) : 706 - 706
  • [2] Number Needed to Harm Reply
    Safer, Daniel J.
    Zito, Julie M.
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2013, 201 (11) : 1003 - 1003
  • [3] Aspirin use and development of inflammatory bowel disease: confounding or causation? authors' reply
    Chan, S. S. M.
    Hart, A. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (11-12) : 1351 - 1351
  • [4] Treatment of anaemia in inflammatory bowel disease: authors' reply
    de Silva, A
    Rampton, DS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1274 - 1275
  • [5] Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Authors' reply
    Asscher, Vera E. R.
    Biemans, Vince B. C.
    Hoentjen, Frank
    Maljaars, P. W. Jeroen
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1617 - 1618
  • [6] Statin Use and Risk of Inflammatory Bowel Diseases: Authors' Reply
    Lochhead, Paul
    Khalili, Hamed
    Sachs, Michael C.
    Chan, Andrew T.
    Olen, Ola
    Ludvigsson, Jonas F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (08): : 1403 - 1404
  • [7] Editorial: anxiety and depression in inflammatory bowel disease - authors' reply
    Stapersma, Luuk
    van den Brink, Gertrude
    Szigethy, Eva M.
    Escher, Johanna C.
    Utens, Elisabeth M. W. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) : 687 - 688
  • [8] The changing epidemiology of paediatric inflammatory bowel disease: authors' reply
    Chouraki, V.
    Turck, D.
    Colombel, J. -F.
    Gower-Rousseau, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (12) : 1381 - 1382
  • [9] Letter: comedication use and dementia risk in patients with inflammatory bowel disease-authors' reply
    Ronnow Sand, Jakob
    Troelsen, Frederikke Schonfeldt
    Horvath-Puho, Erzsebet
    Henderson, Victor W.
    Sorensen, Henrik Toft
    Erichsen, Rune
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (10) : 1505 - 1506
  • [10] Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed-Authors' reply
    Oh, Shin Ju
    Kim, Hyo Jong
    Lee, Chang Kyun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (08) : 840 - 841
12345